KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) EBT Margin (2016 - 2026)

AbbVie has reported EBT Margin over the past 14 years, most recently at 16.05% for Q4 2025.

  • Quarterly EBT Margin rose 3108.0% to 16.05% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 10.79% through Dec 2025, up 419.0% year-over-year, with the annual reading at 10.79% for FY2025, 419.0% up from the prior year.
  • EBT Margin was 16.05% for Q4 2025 at AbbVie, up from 4.53% in the prior quarter.
  • Over five years, EBT Margin peaked at 36.41% in Q1 2022 and troughed at 15.02% in Q4 2024.
  • The 5-year median for EBT Margin is 14.33% (2024), against an average of 15.15%.
  • Year-over-year, EBT Margin surged 3957bps in 2021 and then plummeted -3252bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 28.69% in 2021, then plummeted by -32bps to 19.61% in 2022, then plummeted by -57bps to 8.47% in 2023, then plummeted by -277bps to 15.02% in 2024, then surged by 207bps to 16.05% in 2025.
  • Per Business Quant, the three most recent readings for ABBV's EBT Margin are 16.05% (Q4 2025), 4.53% (Q3 2025), and 10.08% (Q2 2025).